Cyclohexyl 2-hydroxybenzoate
Common Name: |
Cyclohexyl 2-hydroxybenzoate |
IUPAC Name: |
cyclohexyl 2-hydroxybenzoate |
Molecular Formula: |
C13H16O3 |
SMILES: |
C1CCC(CC1)OC(=O)C2=CC=CC=C2O |
Inchi: |
1S/C13H16O3/c14-12-9-5-4-8-11(12)13(15)16-10-6-2-1-3-7-10/h4-5,8-10,14H,1-3,6-7H2 |
Inchi Key: |
NUQDJSMHGCTKNL-UHFFFAOYSA-N |
Cas No: |
25485-88-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
220.26 |
Mass (g/mol) |
220.11 |
Molar Refractivity |
61.67 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
3 |
Rings |
2 |
TPSA |
46.53 |
Hetero Atoms |
3 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
115.00 @ 0.04 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.00017 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.46 |
LogP |
2.882 |
iLOGP |
2.86 |
XLOGP3 |
4.36 |
WLOGP |
2.88 |
MLOGP |
2.39 |
ESOL Log S |
-4.03 |
ESOL Solubility (mg/ml) |
0.021 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-5.05 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.96 |
Silicos-IT Solubility (mg/ml) |
0.24 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.55 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.982 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.455 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |